$ZPTA
Zapata Computing Holdings Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024097220 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $2.001M $0.00
YoY Change
Cost Of Revenue $1.280M $1.150M
YoY Change 11.3%
Gross Profit $721.0K $282.0K
YoY Change 155.67%
Gross Profit Margin 36.03%
Selling, General & Admin $6.500M $2.947M
YoY Change 120.56%
% of Gross Profit 901.53% 1045.04%
Research & Development $1.593M $1.470M
YoY Change 8.37%
% of Gross Profit 220.94% 521.28%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.093M $1.318M
YoY Change 514.19% 265.98%
Operating Profit -$7.372M -$1.318M
YoY Change 459.48% 265.97%
Interest Expense $77.00K $2.851M
YoY Change -97.3% 812.35%
% of Operating Profit
Other Income/Expense, Net -$8.197M $2.851M
YoY Change -387.52% 812.35%
Pretax Income -$15.57M $1.533M
YoY Change -1115.42% -3323.82%
Income Tax $7.000K $23.00K
% Of Pretax Income 1.5%
Net Earnings -$15.58M $1.533M
YoY Change -1115.88% -3323.81%
Net Earnings / Revenue -778.41%
Basic Earnings Per Share -$0.48 -$1.01
Diluted Earnings Per Share -$0.48 $0.05
COMMON SHARES
Basic Shares Outstanding 38.63M 31.98M 4.661M
Diluted Shares Outstanding 32.18M 4.661M

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $415.9K
YoY Change -56.79%
Cash & Equivalents $6.652M $0.00
Short-Term Investments
Other Short-Term Assets $371.2K
YoY Change -42.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $11.01M $787.1K
YoY Change 1299.23% -50.99%
LONG-TERM ASSETS
Property, Plant & Equipment $106.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $244.6M
YoY Change 3.59%
Other Assets $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $174.0K $244.6M
YoY Change -99.93% 3.45%
TOTAL ASSETS
Total Short-Term Assets $11.01M $787.1K
Total Long-Term Assets $174.0K $244.6M
Total Assets $11.19M $245.4M
YoY Change -95.44% 3.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.58M
YoY Change
Accrued Expenses $420.2K
YoY Change 1827.34%
Deferred Revenue $736.0K
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.90M $420.2K
YoY Change 5350.03% 293.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $10.42M
YoY Change 29.24%
Total Long-Term Liabilities $10.42M
YoY Change 29.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.90M $420.2K
Total Long-Term Liabilities $10.42M
Total Liabilities $38.14M $10.84M
YoY Change 251.98% 32.69%
SHAREHOLDERS EQUITY
Retained Earnings -$127.4M -$10.05M
YoY Change 1167.84% 60.98%
Common Stock $4.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$26.96M -$10.05M
YoY Change
Total Liabilities & Shareholders Equity $11.19M $245.4M
YoY Change -95.44% 3.09%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$15.58M $1.533M
YoY Change -1115.88% -3323.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.156M
YoY Change 328.51%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.173M
YoY Change
NET CHANGE
Cash From Operating Activities -1.156M
Cash From Investing Activities 0.000
Cash From Financing Activities 1.173M
Net Change In Cash 17.09K
YoY Change -106.33%
FREE CASH FLOW
Cash From Operating Activities -$1.156M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001843714
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-09-30
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41218
dei Entity Registrant Name
EntityRegistrantName
Zapata Computing Holdings Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1578373
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Federal Street, Floor 20
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02110
dei City Area Code
CityAreaCode
844
dei Local Phone Number
LocalPhoneNumber
492-7282
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
ZPTA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38630827
CY2024Q2 us-gaap Cash
Cash
7164000
CY2023Q4 us-gaap Cash
Cash
3332000
CY2024Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
2505000
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1938000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1344000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
323000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
11013000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5593000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
106000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
156000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
238000
CY2024Q2 ck0001843714 Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
0
CY2023Q4 ck0001843714 Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
1943000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137000
CY2024Q2 us-gaap Assets
Assets
11187000
CY2023Q4 us-gaap Assets
Assets
8067000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11575000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6452000
CY2024Q2 ck0001843714 Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5255000
CY2023Q4 ck0001843714 Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1945000
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
736000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
744000
CY2024Q2 ck0001843714 Deferred Legal Fees Current
DeferredLegalFeesCurrent
2953000
CY2023Q4 ck0001843714 Deferred Legal Fees Current
DeferredLegalFeesCurrent
0
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
75000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
252000
CY2024Q2 ck0001843714 Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
2305000
CY2023Q4 ck0001843714 Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
0
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22899000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9393000
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
13163000
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2024Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
2081000
CY2023Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
8900000
CY2024Q2 us-gaap Liabilities
Liabilities
38143000
CY2023Q4 us-gaap Liabilities
Liabilities
18293000
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
0
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
64716000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
23500000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35255013
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35255013
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4678950
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4678950
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
100545000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14633000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-83000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127422000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89526000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-26956000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-74942000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11187000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8067000
CY2024Q2 us-gaap Revenues
Revenues
2001000
CY2023Q2 us-gaap Revenues
Revenues
1432000
us-gaap Revenues
Revenues
3219000
us-gaap Revenues
Revenues
2944000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
1280000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
1150000
us-gaap Cost Of Revenue
CostOfRevenue
2328000
us-gaap Cost Of Revenue
CostOfRevenue
2456000
CY2024Q2 us-gaap Gross Profit
GrossProfit
721000
CY2023Q2 us-gaap Gross Profit
GrossProfit
282000
us-gaap Gross Profit
GrossProfit
891000
us-gaap Gross Profit
GrossProfit
488000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2193000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1648000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3841000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3349000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1593000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1470000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3007000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3599000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4307000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1299000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6489000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2768000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
8093000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
4417000
us-gaap Operating Expenses
OperatingExpenses
13337000
us-gaap Operating Expenses
OperatingExpenses
9716000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7372000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4135000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12446000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9228000
CY2024Q2 us-gaap Interest Expense
InterestExpense
77000
CY2023Q2 us-gaap Interest Expense
InterestExpense
0
us-gaap Interest Expense
InterestExpense
862000
us-gaap Interest Expense
InterestExpense
0
CY2024Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4935000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2024Q2 ck0001843714 Change In Fair Value Of Forward Purchase Agreement Derivative Liability
ChangeInFairValueOfForwardPurchaseAgreementDerivativeLiability
-8228000
CY2023Q2 ck0001843714 Change In Fair Value Of Forward Purchase Agreement Derivative Liability
ChangeInFairValueOfForwardPurchaseAgreementDerivativeLiability
0
ck0001843714 Change In Fair Value Of Forward Purchase Agreement Derivative Liability
ChangeInFairValueOfForwardPurchaseAgreementDerivativeLiability
-8228000
ck0001843714 Change In Fair Value Of Forward Purchase Agreement Derivative Liability
ChangeInFairValueOfForwardPurchaseAgreementDerivativeLiability
0
CY2024Q2 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
CY2023Q2 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
9776000
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
108000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-558000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1636000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-529000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8197000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-558000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25437000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-529000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15569000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4693000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37883000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9757000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15576000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4716000
us-gaap Net Income Loss
NetIncomeLoss
-37896000
us-gaap Net Income Loss
NetIncomeLoss
-9784000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.1
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32182440
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32182440
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4661256
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4661256
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18383203
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18383203
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4659269
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4659269
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15576000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4716000
us-gaap Net Income Loss
NetIncomeLoss
-37896000
us-gaap Net Income Loss
NetIncomeLoss
-9784000
CY2024Q2 ck0001843714 Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-19000
CY2023Q2 ck0001843714 Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-6000
ck0001843714 Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-34000
ck0001843714 Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-7000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15595000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4722000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37930000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9791000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-57083000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
45000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5068000
CY2023Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-1000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-62101000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
162000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4716000
CY2023Q2 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-6000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-66658000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-74942000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
68000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
191000
CY2024Q1 us-gaap Gain Loss On Repurchase Of Debt Instrument
GainLossOnRepurchaseOfDebtInstrument
9776000
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14660000
CY2024Q1 ck0001843714 Decrease In Temporary Equity Due To Conversion Into Permanent Equity Value
DecreaseInTemporaryEquityDueToConversionIntoPermanentEquityValue
64716000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-22320000
CY2024Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-15000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-21080000
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
229000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15576000
CY2024Q2 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-19000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-26956000
us-gaap Net Income Loss
NetIncomeLoss
-37896000
us-gaap Net Income Loss
NetIncomeLoss
-9784000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86000
us-gaap Paid In Kind Interest
PaidInKindInterest
761000
us-gaap Paid In Kind Interest
PaidInKindInterest
0
ck0001843714 Non Cash Vendor Payments
NonCashVendorPayments
150000
ck0001843714 Non Cash Vendor Payments
NonCashVendorPayments
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9776000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4935000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
ck0001843714 Change In Fair Value Of Senior Notes
ChangeInFairValueOfSeniorNotes
0
ck0001843714 Change In Fair Value Of Senior Notes
ChangeInFairValueOfSeniorNotes
-570000
ck0001843714 Change In Fair Value Of Forward Purchase Agreement Derivative Liability
ChangeInFairValueOfForwardPurchaseAgreementDerivativeLiability
-8228000
ck0001843714 Change In Fair Value Of Forward Purchase Agreement Derivative Liability
ChangeInFairValueOfForwardPurchaseAgreementDerivativeLiability
0
us-gaap Share Based Compensation
ShareBasedCompensation
420000
us-gaap Share Based Compensation
ShareBasedCompensation
207000
ck0001843714 Non Cash Lease Expense
NonCashLeaseExpense
170000
ck0001843714 Non Cash Lease Expense
NonCashLeaseExpense
173000
ck0001843714 Equity Line Of Credit Commitment Expense
EquityLineOfCreditCommitmentExpense
1688000
ck0001843714 Equity Line Of Credit Commitment Expense
EquityLineOfCreditCommitmentExpense
0
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
568000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-280000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
881000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
482000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5457000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1721000
ck0001843714 Increase Decrease In Accrued Expenses Other Current Liabilities And Other Non Current Liabilities
IncreaseDecreaseInAccruedExpensesOtherCurrentLiabilitiesAndOtherNonCurrentLiabilities
-5000
ck0001843714 Increase Decrease In Accrued Expenses Other Current Liabilities And Other Non Current Liabilities
IncreaseDecreaseInAccruedExpensesOtherCurrentLiabilitiesAndOtherNonCurrentLiabilities
-1250000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-279000
ck0001843714 Increase Decrease In Deferred Legal Fees
IncreaseDecreaseInDeferredLegalFees
-378000
ck0001843714 Increase Decrease In Deferred Legal Fees
IncreaseDecreaseInDeferredLegalFees
0
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-178000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-179000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8254000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8937000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2929000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
68000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000
ck0001843714 Issuances Of Common Stock Under Equity Line Of Credit
IssuancesOfCommonStockUnderEquityLineOfCredit
-5300000
ck0001843714 Issuances Of Common Stock Under Equity Line Of Credit
IssuancesOfCommonStockUnderEquityLineOfCredit
0
ck0001843714 Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
12636000
ck0001843714 Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
0
ck0001843714 Proceeds From Partial Early Termination Of Forward Purchase Agreement
ProceedsFromPartialEarlyTerminationOfForwardPurchaseAgreement
2500000
ck0001843714 Proceeds From Partial Early Termination Of Forward Purchase Agreement
ProceedsFromPartialEarlyTerminationOfForwardPurchaseAgreement
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
315000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
ck0001843714 Prepayment For Forward Purchase Agreement
PrepaymentForForwardPurchaseAgreement
10986000
ck0001843714 Prepayment For Forward Purchase Agreement
PrepaymentForForwardPurchaseAgreement
0
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
5878000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
4875000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12152000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4884000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-40000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3832000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4077000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3469000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10210000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7301000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6133000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
14660000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0
ck0001843714 Issuance Of Common Stock In Connection With Debt Issuance Costs Related To Senior Secured Notes And Capital Markets Advisory Agreements
IssuanceOfCommonStockInConnectionWithDebtIssuanceCostsRelatedToSeniorSecuredNotesAndCapitalMarketsAdvisoryAgreements
352000
ck0001843714 Issuance Of Common Stock In Connection With Debt Issuance Costs Related To Senior Secured Notes And Capital Markets Advisory Agreements
IssuanceOfCommonStockInConnectionWithDebtIssuanceCostsRelatedToSeniorSecuredNotesAndCapitalMarketsAdvisoryAgreements
0
us-gaap Notes Issued1
NotesIssued1
1150000
us-gaap Notes Issued1
NotesIssued1
0
ck0001843714 Deferred Offering Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
2793000
ck0001843714 Deferred Offering Costs Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
0
ck0001843714 Debt Issuance Costs Incurred And Included In Accrued Expenses And Other Current Liabilities
DebtIssuanceCostsIncurredAndIncludedInAccruedExpensesAndOtherCurrentLiabilities
35000
ck0001843714 Debt Issuance Costs Incurred And Included In Accrued Expenses And Other Current Liabilities
DebtIssuanceCostsIncurredAndIncludedInAccruedExpensesAndOtherCurrentLiabilities
0
ck0001843714 Temporary Equity Converted Into Permanent Equity Upon Recapitalization
TemporaryEquityConvertedIntoPermanentEquityUponRecapitalization
64716000
ck0001843714 Temporary Equity Converted Into Permanent Equity Upon Recapitalization
TemporaryEquityConvertedIntoPermanentEquityUponRecapitalization
0
ck0001843714 Issuance Of Common Stock In Connection With The Equity Line Of Credit Commitment Shares
IssuanceOfCommonStockInConnectionWithTheEquityLineOfCreditCommitmentShares
1688000
ck0001843714 Issuance Of Common Stock In Connection With The Equity Line Of Credit Commitment Shares
IssuanceOfCommonStockInConnectionWithTheEquityLineOfCreditCommitmentShares
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-15576000
us-gaap Net Income Loss
NetIncomeLoss
-37896000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127422000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89526000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions reflected within these condensed consolidated financial statements include, but are not limited to, revenue recognition, the Forward Purchase Agreement derivative liability, the valuation of the Company’s common stock, and the fair value of stock-based awards. The Company’s estimates are based on historical information available as of the date of the unaudited condensed consolidated financial statements and various other assumptions that the Company believes are reasonable under the circumstances. Actual results may differ materially from those estimates or assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains its cash and cash equivalents at high-quality and accredited financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company performs ongoing credit evaluations of its customers and generally requires no collateral to secure accounts receivable. Accounts receivable is presented after consideration of an allowance for credit losses, which is an estimate of amounts that may not be collectible. In determining the amount of the allowance at each reporting date, the Company makes judgments about general economic conditions, historical write-off experience and any specific risks identified in customer collection matters, including the aging of unpaid accounts receivable and changes in customer financial conditions. Account balances are written off after all means of collection are exhausted and the potential for recovery is determined to not be probable. As of June 30, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company recorded </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> allowance for credit losses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes customers who represent greater than 10% of the Company’s total revenue during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2024, as well as customers who represent greater than 10% of the Company’s total accounts receivable as of June 30, 2024 and December 31, 2023:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:15.24%;"></td> <td style="width:4.24%;"></td> <td style="width:11.12%;"></td> <td style="width:1.94%;"></td> <td style="width:11.12%;"></td> <td style="width:1.94%;"></td> <td style="width:11.12%;"></td> <td style="width:1.94%;"></td> <td style="width:11.12%;"></td> <td style="width:3.02%;"></td> <td style="width:3.02%;"></td> <td style="width:11.12%;"></td> <td style="width:1.94%;"></td> <td style="width:11.12%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="7" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Percentage of Revenue</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="border-left:0.5pt solid #000000;vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Percentage of Accounts Receivable</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Three Months Ended June 30,</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="3" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Six Months Ended June 30,</span></p></td> <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30,<br/>2024</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31,<br/>2023</span></p></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2023</span></p></td> <td style="border-right:0.5pt solid #000000;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer A*</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">58</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">34</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="border-right:0.5pt solid #000000;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">89</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">43</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer B</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="border-right:0.5pt solid #000000;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer C</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="border-right:0.5pt solid #000000;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">31</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer D</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="border-right:0.5pt solid #000000;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Customer E</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="border-right:0.5pt solid #000000;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">N/A**</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">26</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">*Related party</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">**Less than 10% of total revenue or accounts receivable</span></p></div>
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6652000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2693000
CY2024Q2 ck0001843714 Restircted Cash Deposit To Secure Letter Of Credit
RestirctedCashDepositToSecureLetterOfCredit
137000
CY2023Q4 ck0001843714 Restircted Cash Deposit To Secure Letter Of Credit
RestirctedCashDepositToSecureLetterOfCredit
137000
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
7164000
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3332000
CY2024Q2 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
137000
CY2023Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
137000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7301000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3469000
CY2024Q2 ck0001843714 Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
0
CY2023Q4 ck0001843714 Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
1943000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2024Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2024Q2 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
0
CY2023Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
0
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
19000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
38000
CY2024Q2 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
10000
CY2023Q2 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
15000
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
19000
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
19000
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2024Q2 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
1617000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
1341000
CY2024Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
888000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
597000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
736000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
744000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
1341000
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
600000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
597000
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
827000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
744000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
500000
CY2024Q2 us-gaap Revenues
Revenues
2001000
CY2023Q2 us-gaap Revenues
Revenues
1432000
us-gaap Revenues
Revenues
3219000
us-gaap Revenues
Revenues
2944000
CY2024Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2024Q1 ck0001843714 Stock Issued During The Period Shares Restructuring
StockIssuedDuringThePeriodSharesRestructuring
17696425
CY2024Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3016409
CY2024Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.9141
CY2024Q2 ck0001843714 Percentage Of Aggregate Shares Held By The Existing Shareholders
PercentageOfAggregateSharesHeldByTheExistingShareholders
0.63
CY2024Q2 ck0001843714 Number Of Directors
NumberOfDirectors
7
CY2024Q2 ck0001843714 Number Of Independent Directors
NumberOfIndependentDirectors
1
CY2024Q1 us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
7058000
CY2024Q1 us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
150000
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
3333
CY2024Q1 ck0001843714 Reduction In Additional Paid In Capital In The Account Of Capital Market Advisory
ReductionInAdditionalPaidInCapitalInTheAccountOfCapitalMarketAdvisory
450000
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
33333
CY2024Q1 ck0001843714 Cash Payment To Third Party
CashPaymentToThirdParty
1800000
CY2024Q1 ck0001843714 Payment Of Date
PaymentOfDate
of $113 commencing on the earlier of May 31, 2024
CY2024Q1 ck0001843714 Payment Of Condition Amount
PaymentOfConditionAmount
300000
CY2024Q1 ck0001843714 Voluntarily Payment To Third Party
VoluntarilyPaymentToThirdParty
1500000
CY2024Q1 ck0001843714 Payment For Consummation Of A Financing Transaction
PaymentForConsummationOfAFinancingTransaction
1800000
CY2024Q1 ck0001843714 Proceeds From Consummation Of A Financing Transaction
ProceedsFromConsummationOfAFinancingTransaction
15000000
CY2024Q1 ck0001843714 Merger Recognized As Transaction Cost
MergerRecognizedAsTransactionCost
1800000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
226000
CY2024Q1 us-gaap Liabilities
Liabilities
8159000
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
223000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1987000
CY2024Q1 ck0001843714 Deferred Legal Fees Current
DeferredLegalFeesCurrent
3330000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4935000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
809000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
784000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
703000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
628000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
106000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
156000
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
41000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
75000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
86000
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
967000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
263000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3709000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1377000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
579000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
305000
CY2024Q2 ck0001843714 Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5255000
CY2023Q4 ck0001843714 Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1945000
CY2024Q2 ck0001843714 Subscription Receivable From Recycled Shares
SubscriptionReceivableFromRecycledShares
10986000
CY2024Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
2081000
CY2023Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
8900000
CY2024Q2 ck0001843714 Notes Payable To Related Parties Current And Current
NotesPayableToRelatedPartiesCurrentAndCurrent
2305000
CY2023Q4 ck0001843714 Notes Payable To Related Parties Current And Current
NotesPayableToRelatedPartiesCurrentAndCurrent
0
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4386000
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
8900000
CY2024Q2 ck0001843714 Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
2305000
CY2023Q4 ck0001843714 Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
0
CY2024Q2 us-gaap Debt Current
DebtCurrent
2305000
CY2023Q4 us-gaap Debt Current
DebtCurrent
0
CY2024Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
2081000
CY2023Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
8900000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
2081000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
8900000
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4386000
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
8900000
CY2023Q4 us-gaap Senior Notes
SeniorNotes
8900000
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
158000
CY2024Q2 ck0001843714 Senior Secured Notes And Notes Payable To Related Party Future Minimum Payments Due Current Remainder Of Fiscal Year
SeniorSecuredNotesAndNotesPayableToRelatedPartyFutureMinimumPaymentsDueCurrentRemainderOfFiscalYear
1576000
CY2024Q2 ck0001843714 Senior Secured Notes And Notes Payable To Related Party Future Minimum Payments Due In Next Twelve Months
SeniorSecuredNotesAndNotesPayableToRelatedPartyFutureMinimumPaymentsDueInNextTwelveMonths
796000
CY2024Q2 ck0001843714 Senior Secured Notes And Notes Payable To Related Party Future Minimum Payments Due In Two Years
SeniorSecuredNotesAndNotesPayableToRelatedPartyFutureMinimumPaymentsDueInTwoYears
2081000
CY2024Q2 ck0001843714 Senior Secured Notes And Notes Payable To Related Party Future Minimum Payments Due
SeniorSecuredNotesAndNotesPayableToRelatedPartyFutureMinimumPaymentsDue
4453000
CY2024Q2 ck0001843714 Payable Imputed Interest
PayableImputedInterest
-67000
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4386000
CY2024Q1 ck0001843714 Temporary Equity Conversion Into Permanent Equity Exchange Ratio
TemporaryEquityConversionIntoPermanentEquityExchangeRatio
0.9141
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
14222580
CY2024Q1 ck0001843714 Decrease In Temporary Equity Due To Conversion Into Permanent Equity Shares
DecreaseInTemporaryEquityDueToConversionIntoPermanentEquityShares
13001114
CY2024Q1 ck0001843714 Temporary Equity Conversion Into Permanent Equity Exchange Ratio
TemporaryEquityConversionIntoPermanentEquityExchangeRatio
0.9141
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
14647823
CY2023Q4 ck0001843714 Preferred Stock Share Issued And Outstanding
PreferredStockShareIssuedAndOutstanding
13001114
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
64716000
CY2023Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
65004000
CY2023 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
13001114
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
23500000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
3276076
CY2024Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
13001114
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30822000
ck0001843714 Class Of Warrants Or Rights Period After Which The Warrants Or Rights Are Exercisable
ClassOfWarrantsOrRightsPeriodAfterWhichTheWarrantsOrRightsAreExercisable
P30D
CY2024Q1 ck0001843714 Reserve For Common Stock Issuance
ReserveForCommonStockIssuance
3491146
CY2024Q2 ck0001843714 Percentage Of Common Stock Share Outstanding
PercentageOfCommonStockShareOutstanding
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3078475
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.38
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M23D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4489000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
900000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.1
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
47183
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.44
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
415000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
307873
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.12
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3623419
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M26D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2171320
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y4M2D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
8000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3623419
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y5M26D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.66
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
1219000
ck0001843714 Unrecognized Compensation Remaining Weighted Average Period
UnrecognizedCompensationRemainingWeightedAveragePeriod
P2Y7M20D
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
229000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
162000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
420000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
207000
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
1129630
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y
ck0001843714 Aggregate Number Of Trading Days For Determining The Share Price
AggregateNumberOfTradingDaysForDeterminingTheSharePrice
P20D
ck0001843714 Number Of Consecutive Trading Days For Determining The Share Price
NumberOfConsecutiveTradingDaysForDeterminingTheSharePrice
P30D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
0
CY2024Q2 ck0001843714 Percentage Of Fair Market Value Per Share
PercentageOfFairMarketValuePerShare
0.85
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
85000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
101000
us-gaap Operating Lease Cost
OperatingLeaseCost
178000
us-gaap Operating Lease Cost
OperatingLeaseCost
201000
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2000
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2024Q2 us-gaap Lease Cost
LeaseCost
87000
CY2023Q2 us-gaap Lease Cost
LeaseCost
101000
us-gaap Lease Cost
LeaseCost
181000
us-gaap Lease Cost
LeaseCost
201000
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0
us-gaap Variable Lease Cost
VariableLeaseCost
0
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0
us-gaap Variable Lease Cost
VariableLeaseCost
0
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
185000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
207000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1105
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
75000
CY2024Q2 ck0001843714 Lessee Operating Lease Liability Payments After Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsAfterRemainderOfFiscalYear
0
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
75000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
0
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
75000
CY2024Q2 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
7000
CY2023Q2 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
23000
us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
13000
us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
27000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 ck0001843714 Non Refundable Cash Fee Payable Over The Term To Related Party
NonRefundableCashFeePayableOverTheTermToRelatedParty
113000
CY2024Q2 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
3232000
CY2024Q2 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
2906000
CY2024Q2 us-gaap Other Commitment
OtherCommitment
6138000
CY2024Q1 ck0001843714 Agreement Periods
AgreementPeriods
P24M
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32182440
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32182440
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4661256
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4661256
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18383203
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18383203
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4659269
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4659269
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.1
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30056890
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15609763
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30056890
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15609763

Files In Submission

Name View Source Status
0000950170-24-097220-index-headers.html Edgar Link pending
0000950170-24-097220-index.html Edgar Link pending
0000950170-24-097220.txt Edgar Link pending
0000950170-24-097220-xbrl.zip Edgar Link pending
ck0001843714-20240630.htm Edgar Link pending
ck0001843714-20240630.xsd Edgar Link pending
ck0001843714-ex10_29.htm Edgar Link pending
ck0001843714-ex10_32.htm Edgar Link pending
ck0001843714-ex10_33.htm Edgar Link pending
ck0001843714-ex31_1.htm Edgar Link pending
ck0001843714-ex31_2.htm Edgar Link pending
ck0001843714-ex32_1.htm Edgar Link pending
ck0001843714-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img132712806_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ck0001843714-20240630_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable